Investors / United Kingdom / Manta Ray
Manta Ray
Venture capital · London, United Kingdom · Europe
Manta Ray is a venture capital firm backed by a single European family office, managing over $250m across about 50 active portfolio companies. It invests in early-stage companies and supports entrepreneurship in Poland and Central and Eastern Europe as a bridge to ecosystems in Europe and the US.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordshuman healthbiologyeducationprivacysecuritybuilt environment
Your fit with Manta Ray
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsManta Ray lists 55 checked portfolio companies on its own site and is named in 7 funding rounds. Its most frequent entry is Seed, 43% of the companies with a known first round. Its largest themes are Healthcare & Biotech (25%), AI & Machine Learning (19%) and Enterprise Software (11%). 57% of its companies are based in United States. It invests most often alongside Creative Destruction Lab, General Catalyst and Fifty Years.
Counts come from funding rounds that name Manta Ray, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Manta Ray's whole history. Rounds on record name 7 companies; its own site lists 55. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 43% |
| Series A | 29% |
| Series B | 29% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 3 | 0 |
| '26 | 4 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 86th | 55 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 67th | 43% of entries at pre-seed or seed |
| Evidence | 79th | 11% of companies confirmed by a round |
| Sector focus | 37th | 25% in its largest sector |
| Reach | 84th | 6 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 25% | 15% |
| AI & Machine Learning | 19% | 18% |
| Enterprise Software | 11% | 8% |
| Real Estate & Construction | 8% | 3% |
| Food & Agriculture | 7% | 3% |
| Cybersecurity | 5% | 4% |
| Fintech | 5% | 12% |
| E-commerce & Marketplaces | 5% | 6% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 4 |
| General Catalyst | 4 |
| Fifty Years | 3 |
| Abstract | 2 |
| Actions Capital | 2 |
| Andreessen Horowitz | 2 |
| Backed | 2 |
| Beni VC | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5396%
- No longer answers00%
- Points to another company24%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Manta Ray head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Manta Ray| Date | Company | Stage |
|---|---|---|
| 12 Nov 2026 | Seed | |
| 25 May 2026 | Seed | |
| 1 Apr 2026 | Seed | |
| 12 Jan 2026 | Series B | |
| 22 Jul 2025 | Series A | |
| 10 Jul 2025 | Series B |
Round details for Manta Ray
Amounts, full round histories and every co-investor in Manta Ray's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
55 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company does organism level drug discovery | Healthcare & Biotech | Portfolio page | ||
| Alien is a fair, decentralized human network that lets you establish proof of humanity without sacrificing your privacy or agency. | AI & Machine LearningCybersecurity | Apr 2026Seed | Page + round | |
| Aqtual analyzes tissue biology from a blood draw. | Healthcare & Biotech | Jul 2025Series B | Page + round | |
| The company provides construction management software for contractors. | Real Estate & Construction | Portfolio page | ||
| Assembly OSM builds affordable homes using a manufactured building platform | Real Estate & Construction | Portfolio page | ||
| Astranis designs, manufactures, tests, and operates geostationary orbit satellites for commercial and government customers. | Space & DefenseAI & Machine Learning | Portfolio page | ||
| Beacon provides a platform for supply chain management and finance, offering features such as shipment tracking and invoice reconciliation. | FintechHealthcare & Biotech | Portfolio page | ||
| BEIT provides computational drug discovery services for small-molecule teams using physics-based modeling | Healthcare & Biotech | Portfolio page | ||
| Believer produces cultivated meat from high-quality, non-GMO animal cells. | Food & Agriculture | Portfolio page | ||
| Bettani produces dairy-free cheese alternatives with high protein content | Food & Agriculture | Portfolio page | ||
| The company produces dairy products using precision fermentation for human nutrition | Food & Agriculture | Portfolio page | ||
| BLUU develops marine ingredients through controlled biomanufacturing | Healthcare & Biotech | Portfolio page | ||
| Booksy allows users to discover and book appointments with beauty and wellness professionals near them. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| The company designs custom, architect-grade spaces and builds them in weeks, not years. | Real Estate & Construction | Portfolio page | ||
CybersecurityAI & Machine Learning | Portfolio page | |||
| Cetos treats complex industrial wastewater that conventional technologies can’t handle economically, creating new sources of freshwater and critical minerals for operations. | Industrial & ManufacturingEnterprise Software | Portfolio page | ||
| The company provides an app to manage and optimize insurance policies | FintechHealthcare & Biotech | Portfolio page | ||
| CoinPaprika provides cryptocurrency prices, market capitalization, and charts. | Fintech | Portfolio page | ||
| Cuemath provides personalized online math tutoring for students | Education | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mantaray.vc
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 10 Jul 2025
- Companies checked
- 55
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Manta Ray's profile as data
Pull Manta Ray's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mantaray.vc
# also
GET /v1/firms/mantaray.vc/portfolio
GET /v1/firms/mantaray.vc/coinvestors
GET /v1/firms/mantaray.vc/news